StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pacira Pharma (PCRX) Confims Trading Halt Ahead of FDA AdCom
February 14, 2018 1:29 PM
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that NASDAQ has halted trading of the company’s common stock.The U.S. Food and ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Trading Halts
Next Articles
Pacira Pharma (PCRX) to Resume Trading at 4:15 pm ET
February 15, 2018 3:51 PM
Pacira Pharma (PCRX) Doesn't Win FDA Panel Backing of EXPAREL in 6 to 4 Vote Against Approval
February 15, 2018 3:01 PM
Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
February 14, 2018 1:27 PM
Pacira Pharma (PCRX) halted, news pending
February 14, 2018 1:25 PM
Pacira Pharma (PCRX) Confirms FDA EXPAREL Briefing Docs Posted
February 12, 2018 1:31 PM
FDA Posts Briefing Documents for Advisory Meeting Reviewing sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
February 12, 2018 1:30 PM
FDA Posts Briefing Documents for Advisory Meeting Reviewing sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
February 12, 2018 1:29 PM
FDA staff report on Pacira Pharma (PCRX) Exparel available ahead of Feb 14-15 meeting - Bloomberg
February 12, 2018 1:27 PM
